Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
AquaBounty raises genetically engineered Atlantic salmon in indoor tanks on land and sells them as food.
AquaBounty is a fish farming company with a twist: the fish it raises are genetically engineered Atlantic salmon that grow to market size roughly twice as fast as ordinary salmon. The company grows them indoors in tanks on land, far from the ocean, and sells the fillets to restaurants and grocery customers. Most salmon farming happens in open-net pens in the sea, which can leak fish and waste into surrounding waters. AquaBounty's indoor, land-based approach is meant to avoid that, and its salmon was the first genetically engineered animal ever approved for human food in the United States.
The biology is simple. The company's salmon carry a growth-hormone gene from a different salmon species plus a genetic "on switch" from an eel-like fish called ocean pout, so the fish produce growth hormone year-round instead of only in warmer months. They reach a sellable size in about 18 months rather than three years, which means less feed and less time in the tanks. Regulators in the US, Canada, and other markets have reviewed and approved the fish as safe to eat. The hard part is money. AquaBounty has never turned a profit. It built and ran a farm in Indiana, and its main production site is on Canada's Prince Edward Island, where it grows salmon and operates a hatchery. Land-based aquaculture is capital-hungry: pumps, tanks, heating, oxygen, and water treatment all cost a lot to build and run, and the company has repeatedly raised cash from investors to stay afloat. In late 2024 it announced it was winding down its Rollo Bay farm operations on Prince Edward Island and laying off staff as part of a restructuring to conserve cash and focus on the Indiana site. That is the central tension of the story: a clever piece of science with a business model that has not yet proven it can make money.
The idea has real appeal, though. Salmon is one of the most popular seafoods in America, and much of it is imported from Chile and Norway. A domestic, disease-resistant, fast-growing fish raised on land could, in theory, shorten supply chains and sidestep the environmental criticisms of ocean pens. Whether AquaBounty can scale that idea into a profitable business is the question investors are still waiting on.
Saved answer 路 last researched 15 Nov 2026